We are live on ! Find out more
Wells Fargo

Wells Fargo Portfolio holdings

AUM $530B
1-Year Est. Return 22.01%
 

Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.

This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
+22.01%
3 Year Est. Return
+63.17%
5 Year Est. Return
+74.8%
10 Year Est. Return
+285.95%
AUM
$271B
AUM Growth
+$13.1B
Cap. Flow
+$4.49B
Cap. Flow %
1.65%
Top 10 Hldgs %
12.56%
Holding
6,697
New
323
Increased
2,847
Reduced
2,381
Closed
277

Sector Composition

Rank Sector Weight
1 Technology 10.89%
2 Healthcare 9.59%
3 Industrials 8.62%
4 Financials 8.11%
5 Consumer Discretionary 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMD
6176
DELISTED
Psychemedics Corporation
PMD
-1
Closed -$19
VGR
6177
PUT
DELISTED
Vector Group Ltd.
VGR
-85,693
Closed -$10K
HA
6178
PUT
DELISTED
Hawaiian Holdings, Inc.
HA
-69,000
Closed -$349K
AAMC
6179
DELISTED
Altisource Asset Management Corp
AAMC
$0 ﹤0.01%
2
BIOL
6180
DELISTED
Biolase, Inc.
BIOL
0
SCPX
6181
DELISTED
Scorpius Holdings, Inc.
SCPX
0
MRNS
6182
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-125
Closed -$1K
NURO
6183
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
0
NBSE
6184
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
0
YTEN
6185
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
CBD
6186
DELISTED
Companhia Brasileira de Distribuicao
CBD
$0 ﹤0.01%
1
NEPT
6187
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
0
GOL
6188
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-5
Closed -$18
SRT
6189
DELISTED
Startek Inc.
SRT
$0 ﹤0.01%
1
FRTX
6190
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
0
CTG
6191
DELISTED
Computer Task Group, Inc.
CTG
-1
Closed -$5
AVTA
6192
PUT
DELISTED
Avantax, Inc. Common Stock
AVTA
-80,000
Closed -$1K
USDP
6193
DELISTED
USD PARTNERS LP
USDP
-1
Closed -$11
CYTO
6194
DELISTED
Altamira Therapeutics Ltd
CYTO
0
EMAN
6195
DELISTED
eMagin Corporation
EMAN
$0 ﹤0.01%
20
UBP
6196
DELISTED
Urstadt Biddle Properties Inc.
UBP
$0 ﹤0.01%
1
MTEM
6197
DELISTED
Molecular Templates, Inc.
MTEM
0
PDCE
6198
CALL
DELISTED
PDC Energy, Inc.
PDCE
-52,200
Closed -$27K
TCFC
6199
DELISTED
The Community Financial Corporation Common Stock
TCFC
-1
Closed -$23
BNSO
6200
DELISTED
Bonso Electronic International
BNSO
$0 ﹤0.01%
1

Similar funds

Wells Fargo's Q3 2016 Portfolio in Review

As of Q3 2016, Wells Fargo held 6,697 positions worth $271B, up 5.1% from $258B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Wells Fargo's Q3 2016 filing shows 323 new, 2,847 increased, 2,381 reduced and 277 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 4,857,090 shares worth $159M. The largest sale was Bristol-Myers Squibb, an estimated $430M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.9% a quarter earlier, followed by Healthcare and Industrials.

  • Wells Fargo's largest Q3 2016 buy was State Street Real Estate Select Sector SPDR ETF: 4,857,090 shares worth $159M.
  • Wells Fargo added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $2.28B increase.
  • Wells Fargo's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $430M.
  • Wells Fargo fully exited EMC CORPORATION in Q3 2016, selling an estimated $172M.
  • Wells Fargo's ten largest holdings make up 13% of its $271B portfolio in Q3 2016.
  • Wells Fargo opened 323 new positions and closed 277 in Q3 2016.
  • Wells Fargo's portfolio value rose 5.1% quarter-over-quarter to $271B.

Based on Wells Fargo's 13F filing for Q3 2016, filed 31 Oct 2016.